Form D — Aptevo Therapeutics Inc.
0001193125-26-368286 · filed Aug 26, 2026
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06c
- Total offering
- $3,472,683
- Total sold
- $3,472,683
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Aptevo Therapeutics Inc.
- CIK
- 1671584
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 2401 4th Ave.
Seattle, WA 98121 - Phone
- 206-838-0500
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jeffrey G Lamothe · Executive OfficerSeattle, WA Find on LinkedIn ↗
-
Marvin L White · Executive OfficerSeattle, WA Find on LinkedIn ↗
-
Daphne Taylor · Executive OfficerSeattle, WA Find on LinkedIn ↗
-
John E Niederhuber · DirectorSeattle, WA Find on LinkedIn ↗
-
Daniel J Abdun-Nabi · DirectorSeattle, WA Find on LinkedIn ↗
-
Grady Grant III · DirectorSeattle, WA Find on LinkedIn ↗
-
Zsolt Harsanyi · DirectorSeattle, WA Find on LinkedIn ↗
-
Barbara Lopez Kunz · DirectorSeattle, WA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗